This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: **Spotlight on Inventor Srinivasa P S Rao**
Introduction
Srinivasa P S Rao, an accomplished inventor based in Singapore, has made significant contributions to the field of medicine. His innovative work primarily focuses on developing novel compounds that aid in the treatment of tuberculosis, a bacterial infection that poses a serious global health challenge.
Latest Patents
Srinivasa holds one patent titled "Pyridone derivatives and uses thereof in the treatment of tuberculosis." This patent presents a compound of Formula (I) that is valuable for treating diseases mediated by the inhibition of mycolic acid biosynthesis, achieved through the inhibition of the Enoyl Acyl Carrier Protein Reductase enzyme (InhA). The documented formulations and applications can play a crucial role in addressing tuberculosis and enhancing patient outcomes.
Career Highlights
Srinivasa is currently employed at Novartis AG, a prominent multinational pharmaceutical company. His dedication to pharmaceutical innovation drives his research efforts, focusing on developing effective treatments for critical health issues. Throughout his career, he has showcased a commitment to advancing therapeutic options through scientific exploration and innovation.
Collaborations
Srinivasa has collaborated with notable colleagues, including Ravinder Reddy Kondreddi and Ngai Ling Ma. These partnerships underscore the collaborative spirit of innovation within the pharmaceutical industry. Working together, they contribute valuable insights and expertise that further fuel advancements in treatment methodologies.
Conclusion
In summary, Srinivasa P S Rao exemplifies the spirit of innovation through his impactful patent work and collaborations in the pharmaceutical sector. His focus on developing treatments for tuberculosis reflects the importance of scientific research in addressing pressing health challenges. As he continues his career at Novartis AG, his contributions will undoubtedly influence the future of medicine and improve the lives of many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile